Clinical Trial Update: A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia [NA]

View source ↗

Summary

A completed clinical trial (NCT04694820) evaluated a mobile intervention (txt4TKI) to improve management of tyrosine kinase inhibitors in patients with chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Bcr-abl1 Positive

Snippet

Sponsor: Thomas Jefferson University | Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia | NA | Status: COMPLETED